CXS Therapeutics
An accelerated drug discovery platform
2023
Guillaume Brachet - CEO
Pharmacist and researcher, specialised in biopharmaceutical innovation
Why Valeureux invested
A rare chance to take part in building a Tech Bio company. First hits in Parkinson's disease, ALS and Marfan syndrome.
Co-investors
